TARS
NASDAQ · Pharmaceuticals
Tarsus Pharmaceuticals Inc
$78.09
-0.94 (-1.19%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+40.37%
YTD
-3.32%
Open$78.67
Previous Close$79.03
Day High$79.10
Day Low$77.33
52W High$91.53
52W Low$50.71
Volume—
Avg Volume805.9K
Market Cap3.41B
P/E Ratio—
EPS$-1.08
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$73.37
Above
SMA 200
$59.46
Above
RSI (14)
49.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+4.4% upside
Current
$78.09
$78.09
Target
$81.52
$81.52
$66.63
$81.52 avg
$107.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 467.23M | 141.37M | 563.29M |
| Net Income | -68,755,713 | -80,362,652 | 118.73M |
| Profit Margin | -14.7% | -60.0% | 21.1% |
| EBITDA | -72,579,319 | -89,061,843 | 174.10M |
| Free Cash Flow | — | — | 127.20M |
| Rev Growth | +159.5% | +47.5% | +0.6% |
| Debt/Equity | 0.21 | 0.32 | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,167.40 | +1.26% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $271.03 | +0.39% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.15 | +2.23% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.89 | +0.83% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.98 | -0.13% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.79 | +0.55% | 11.5 | 30.15B |